Marcela Maus, M.D., Ph.D.

Funded by the Stuart Scott Memorial Cancer Research Fund

Multiple myeloma is an incurable cancer of plasma cells. There is no cure for multiple myeloma yet. The T cells of the immune system can protect us in the long term from infections and from cancer. Here, we propose to engineer human T cells so they can recognize and kill myeloma tumor cells. This project will test several ways of engineering the T cells to make them as safe as possible and as effective as possible. Our goal is to use this information to treat human patients with multiple myeloma.

Location: Massachusetts General Hospital Cancer Center - Massachusetts
Proposal: Design and pre-clinical evaluation of CAR T cells for myeloma
Mailing List Mailing List
Close Mailing List